Bioactive Compounds
-
N2898 Hydrocortisone butyrateSummary: A potent synthetic glucocorticoid receptor (GR) agonist. -
B3379 Verbascoside3 CitationSummary: PKC/NF-κB inhibitor -
BA1934 NSC727447Summary: NSC727447 is a ribonuclease H (RnaseH) inhibitor of -1 and -2. -
N2897 Levofloxacin hemihydrateSummary: A broad-spectrum third-generation fluoroquinolone antibiotic that targets bacterial DNA gyrase and topoisomerase IV. -
B2212 Moexipril HClSummary: ACE inhibitor -
BA1932 APOBEC3G-IN-1Summary: APOBEC3G-IN-1 (MN136.0185) is a potent inhibitor. -
N2896 Sodium aescinateSummary: A triterpenoid saponin compound that regulates the CARMA3/NF-κB signaling pathway. -
B2203 Candesartan CilexetilTarget: Angiotensin AT2 ReceptorsSummary: Prodrug of the angiotensin II receptor 1 (AT1) antagonist candesartan -
BA1931 EmivirineSummary: Emivirine (MKC-442) is a potent inhibitor of non-nucleoside reverse transcriptases with values of 0.20 and 0.01 μM for dTTP- and dGTP-dependent DNA or RNA polymerase activity, respectively. -
N2895 IsoquercitrinSummary: A natural polyphenolic flavonoid inhibitor of the Wnt/β-catenin pathway.
